Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Evaluation of a Capillary Microsampling Device for Analyzing Plasma Lenvatinib Concentration in Patients With Hepatocellular Carcinoma

View through CrossRef
Background: The anticancer drug, Lenvima (lenvatinib), has severe side effects. Therapeutic drug monitoring helps ensure its efficacy and safety. Regular and optimally timed blood sampling is tough, especially when lenvatinib is self-medicated. Microsampling using the easy to handle Microsampling Wing (MSW) may help circumvent this problem. However, current lenvatinib detection methods are not sensitive enough to detect its concentrations in microsamples (<50–250 μL). Thus, the aim of this study was 2-fold (1) develop an analytic method to estimate plasma lenvatinib concentrations in microsamples and (2) verify whether this method works on micro (5.6 μL) blood plasma samples obtained clinically through MSW from patients with unresectable hepatocellular carcinoma (HCC). Methods: A simple, highly sensitive, and specific liquid chromatography–electrospray ionization tandem mass spectrometry method was developed. Using this novel protocol, the trough blood plasma concentration of lenvatinib was measured for both blood sampled conventionally and that using MSW. Thirty-five venous whole blood samples were obtained from 11 patients with HCC. Furthermore, the stability of lenvatinib in MSW samples during storage was evaluated. Results: The mean plasma lenvatinib concentration estimates were not significantly different between the MSW and conventional venous blood samples. CV for interday and intraday assays was low. Up to day 5, the lenvatinib concentration in the MSW samples was 85%–115% of the initial day concentration (when stored at 25°C or 4°C). The interference of endogenous matrix components in the human plasma was low. Conclusions: These results indicate that the novel mass spectrometry protocol accurately measures lenvatinib in human plasma and is reproducible. Thus, MSW could be a useful microsampling device for lenvatinib therapeutic drug monitoring in patients with HCC when used in combination with this novel liquid chromatography–electrospray ionization tandem mass spectrometry detection method.
Title: Evaluation of a Capillary Microsampling Device for Analyzing Plasma Lenvatinib Concentration in Patients With Hepatocellular Carcinoma
Description:
Background: The anticancer drug, Lenvima (lenvatinib), has severe side effects.
Therapeutic drug monitoring helps ensure its efficacy and safety.
Regular and optimally timed blood sampling is tough, especially when lenvatinib is self-medicated.
Microsampling using the easy to handle Microsampling Wing (MSW) may help circumvent this problem.
However, current lenvatinib detection methods are not sensitive enough to detect its concentrations in microsamples (<50–250 μL).
Thus, the aim of this study was 2-fold (1) develop an analytic method to estimate plasma lenvatinib concentrations in microsamples and (2) verify whether this method works on micro (5.
6 μL) blood plasma samples obtained clinically through MSW from patients with unresectable hepatocellular carcinoma (HCC).
Methods: A simple, highly sensitive, and specific liquid chromatography–electrospray ionization tandem mass spectrometry method was developed.
Using this novel protocol, the trough blood plasma concentration of lenvatinib was measured for both blood sampled conventionally and that using MSW.
Thirty-five venous whole blood samples were obtained from 11 patients with HCC.
Furthermore, the stability of lenvatinib in MSW samples during storage was evaluated.
Results: The mean plasma lenvatinib concentration estimates were not significantly different between the MSW and conventional venous blood samples.
CV for interday and intraday assays was low.
Up to day 5, the lenvatinib concentration in the MSW samples was 85%–115% of the initial day concentration (when stored at 25°C or 4°C).
The interference of endogenous matrix components in the human plasma was low.
Conclusions: These results indicate that the novel mass spectrometry protocol accurately measures lenvatinib in human plasma and is reproducible.
Thus, MSW could be a useful microsampling device for lenvatinib therapeutic drug monitoring in patients with HCC when used in combination with this novel liquid chromatography–electrospray ionization tandem mass spectrometry detection method.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 1739: Reversal of lenvatinib resistance by curcumin via EGFR signaling pathway in hepatocellular carcinoma
Abstract 1739: Reversal of lenvatinib resistance by curcumin via EGFR signaling pathway in hepatocellular carcinoma
Abstract Background: Patients with unresectable advanced hepatocellular carcinoma (HCC) are often treated with systemic therapies, and lenvatinib is currently used a...
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Lenvatinib is approved as a first-line treatment for unresectable H...
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
AbstractHepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Lenvatinib is approved as a first-line treatment for unresectable HCC. The therapeutic...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract Introduction Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma
Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma
AbstractBackground and AimMolecular‐targeted therapies such as sorafenib and lenvatinib have long been used as first‐line treatment for advanced hepatocellular carcinoma (aHCC). Ho...

Back to Top